Humacyte Inc (HUMA) Price Prediction & ForecastHUMAHumacyte Inc

Alphio's HUMA stock price prediction model matches the current Humacyte Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.65 (+0.61%). The 1-week path is $0.66 (+0.77%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Humacyte Inc is currently priced at $0.6501, which is significantly below the analyst price targets of $1 to $4, indicating potential upside. However, the company has a high forward P/E of 35.84, suggesting that it may be overvalued relative to its earnings potential. Additionally, the recent RSI of 45.646 indicates that the stock is neither overbought nor oversold, suggesting caution. The main risk is the company's significant net income loss of -36802000 in Q2 2026, which raises concerns about its financial health.

Humacyte Inc (HUMA) last closed at $0.6501, losing -6.15%. These facts feed the 1-day and 1-week HUMA price prediction above.